 |
市场调查报告书
商品编码
1899318
聚合酵素链锁反应(PCR) 市场规模、份额和成长分析（按类型、产品类型、适应症、最终用户和地区划分）—2026-2033 年产业预测Polymerase Chain Reaction (PCR) Market Size, Share, and Growth Analysis, By Type (Standard PCR, Real-time PCR), By Product (Instruments, Reagents & Consumables), By Indication, By End User, By Region - Industry Forecast 2026-2033 |
||||||
预计到 2024 年，聚合酵素链锁反应(PCR) 市场规模将达到 109.5 亿美元，到 2025 年将达到 118.7 亿美元，到 2033 年将达到 226.3 亿美元，预测期（2026-2033 年）的复合年增长率为 8.4%。
全球聚合酵素链锁反应(PCR) 市场正经历显着扩张，并已成为分子生物学和诊断领域的关键技术。 PCR 能够扩增和分析 DNA 和 RNA，使其在包括研究、临床诊断、法医学分析和生物技术在内的多种应用中发挥着至关重要的作用。成长要素包括感染疾病率的上升、对个人化医疗日益增长的需求、基因组学研究的进展以及对快速准确诊断工具的需求。众多主要企业已进入市场，提供种类繁多的 PCR 仪器、耗材和服务。技术创新已将传统的 PCR 方法发展为高效的自动化系统，例如即时PCR和数位 PCR，这些系统能够提供更快的检测结果和更高的灵敏度。此外，携带式PCR 设备正在扩大其在照护现场检测环境中的市场进入。
聚合酵素链锁反应(PCR) 市场驱动因素
聚合酵素链锁反应(PCR) 市场成长的主要驱动力在于其在分子诊断领域的广泛应用，可用于识别和追踪包括感染疾病、癌症和遗传性疾病在内的多种疾病。近期全球健康挑战凸显了人们对精准快速诊断工具日益增长的需求，进一步推动了基于 PCR 的检测和诊断解决方案的发展。随着医疗系统和实验室寻求可靠的方法来加强疾病的检测和管理，这一趋势预示着 PCR 市场将持续成长。因此，PCR 技术在现代医学中的重要性日益凸显，并促进了其广泛应用。
聚合酵素链锁反应（PCR）市场限制
PCR设备和耗材的高成本对小规模实验室、诊所和研究机构构成重大障碍。这种经济负担限制了PCR技术的普及，阻碍了其广泛应用，尤其是在资源匮乏的地区。因此，价格承受能力问题限制了市场成长，尤其是在经济拮据更为突出的发展中地区。投资这些关键工具的困难会阻碍监测和诊断技术的进步，并最终阻碍依赖PCR调查方法的医疗保健解决方案的发展。解决这些成本障碍对于扩大PCR技术在各种医疗保健环境中的应用范围和有效性至关重要。
聚合酵素链锁反应（PCR）市场趋势
受对快速便捷诊断能力的需求不断增长的推动，PCR市场正经历着向照护现场（POC）解决方案的显着转变。这一趋势主要源自于紧急情况下，尤其是在感染疾病防治领域，对快速检测结果的需求。医疗机构正在积极寻求兼具检测效率和即时结果的POC PCR检测方案，这使得这些设备在临床和社区医疗机构中都具有不可估量的价值。随着及时诊断在医疗机构中持续占据重要地位，POC PCR技术的应用预计将显着增长，从而进一步巩固其市场地位。
目录
介绍
- 调查目标
- 调查范围
- 定义
调查方法
- 资讯收集
- 二手资料和一手资料方法
- 市场规模预测
- 市场假设与限制
执行摘要
- 全球市场展望
- 供需趋势分析
- 细分市场机会分析
市场动态与展望
- 市场规模
- 市场动态
- 驱动因素和机会
- 限制与挑战
- 波特分析
关键市场考察
- 关键成功因素
- 竞争程度
- 关键投资机会
- 市场生态系统
- 市场吸引力指数（2025）
- PESTEL 分析
- 总体经济指标
- 价值链分析
- 定价分析
- 监管环境
- 案例研究
- 技术进步
全球聚合酵素链锁反应(PCR) 市场规模（按类型和复合年增长率划分）（2026-2033 年）
- 标准PCR
- 即时PCR
- 数位PCR
全球聚合酵素链锁反应(PCR) 市场规模（按产品和复合年增长率划分）（2026-2033 年）
- 装置
- 试剂和耗材
全球聚合酵素链锁反应(PCR) 市场规模（按适应症和复合年增长率划分）（2026-2033 年）
- 感染疾病
- 肿瘤学
- 遗传性疾病
- 其他的
全球聚合酵素链锁反应(PCR) 市场规模（依最终用户划分）及复合年增长率 (2026-2033)
- 医院和诊所
- 製药和生物技术产业
- 诊断中心
- 学术和研究机构
全球聚合酵素链锁反应（PCR）市场规模及复合年增长率（2026-2033）
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲地区
- 中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区
竞争资讯
- 前五大公司对比
- 主要企业的市场定位（2025 年）
- 主要市场参与者所采取的策略
- 近期市场趋势
- 公司市占率分析（2025 年）
- 主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较
主要企业简介
- Abbott Laboratories（USA）
- Agilent Technologies（USA）
- Thermo Fisher Scientific（USA）
- Siemens Healthineers（Germany）
- bioMerieux（France）
- Becton, Dickinson and Company（USA）
- Bio-Rad Laboratories（USA）
- Merck KGaA（Germany）
- PerkinElmer（USA）
- Promega Corporation（USA）
- Danaher Corporation（USA）
- QIAGEN（Netherlands）
- QuantuMDx Group Ltd（UK）
- Eppendorf（Germany）
- Fluidigm Corporation（USA）
- Microsynth AG（Switzerland）
- JN Medsys（Singapore）
- Takara Bio Inc（Japan）
结论与建议
Polymerase Chain Reaction (PCR) Market size was valued at USD 10.95 Billion in 2024 and is poised to grow from USD 11.87 Billion in 2025 to USD 22.63 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).
The global polymerase chain reaction (PCR) market is experiencing significant expansion, emerging as an essential technology in molecular biology and diagnostics. PCR's adaptability for amplifying and analyzing DNA and RNA makes it vital across diverse applications, including research, clinical diagnostics, forensic analysis, and biotechnology. Key growth drivers include a rising incidence of infectious diseases, increasing demand for personalized medicine, advancements in genomics research, and the necessity for rapid and precise diagnostic tools. The market features numerous prominent players offering an extensive array of PCR equipment, consumables, and services. Innovations are leading traditional PCR methods towards more efficient automated systems, such as real-time and digital PCR, which provide quicker results and enhanced sensitivity. Moreover, portable PCR devices are broadening market access in point-of-care environments.
Top-down and bottom-up approaches were used to estimate and validate the size of the Polymerase Chain Reaction (PCR) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Polymerase Chain Reaction (PCR) Market Segments Analysis
Global Polymerase Chain Reaction (PCR) Market is segmented by Type, Product, Indication, End User and region. Based on Type, the market is segmented into Standard PCR, Real-time PCR and Digital PCR. Based on Product, the market is segmented into Instruments and Reagents & Consumables. Based on Indication, the market is segmented into Infectious Diseases, Oncology, Genetic Disorders and Others. Based on End User, the market is segmented into Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Diagnostic Centers and Academic & Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Polymerase Chain Reaction (PCR) Market
The Polymerase Chain Reaction (PCR) market is significantly propelled by its widespread application in molecular diagnostics for the identification and tracking of various diseases, including infectious diseases, cancers, and genetic disorders. The increasing demand for accurate and timely diagnostic tools, especially highlighted by recent global health challenges, has escalated the need for PCR-based tests and diagnostic solutions. This trend illustrates a sustained growth trajectory for the PCR market, as healthcare systems and laboratories seek reliable methods to enhance disease detection and management. Consequently, the relevance of PCR technology in contemporary healthcare continues to strengthen, supporting its extensive utilization.
Restraints in the Polymerase Chain Reaction (PCR) Market
The high costs associated with PCR units and consumables present a significant obstacle for smaller laboratories, clinics, and research institutions. This financial burden limits access to PCR technology, particularly in resource-limited environments, hindering its widespread adoption. As a result, the affordability issue restricts market growth, especially in developing regions where financial constraints are more pronounced. The inability to invest in these essential tools may prevent advancements in research and diagnostics, ultimately impeding the overall progress of healthcare solutions reliant on PCR methodologies. Addressing these cost barriers is crucial for expanding the reach and effectiveness of PCR applications in various healthcare settings.
Market Trends of the Polymerase Chain Reaction (PCR) Market
The PCR market is experiencing a notable shift towards point-of-care (POC) testing solutions, driven by the increasing need for rapid and convenient diagnostic capabilities. This trend is largely fueled by the demand for swift results in critical situations, particularly in the context of infectious disease management. Healthcare providers are actively seeking POC PCR testing options that offer efficiency in testing and immediacy in results, making these devices invaluable in both clinical settings and community health initiatives. As the landscape of healthcare continues to prioritize timely diagnostics, the adoption of POC PCR technologies is expected to expand significantly, reinforcing their market presence.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2025
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Regulatory Landscape
- Case Studies
- Technological Advancement
Global Polymerase Chain Reaction (PCR) Market Size by Type & CAGR (2026-2033)
- Market Overview
- Standard PCR
- Real-time PCR
- Digital PCR
Global Polymerase Chain Reaction (PCR) Market Size by Product & CAGR (2026-2033)
- Market Overview
- Instruments
- Reagents & Consumables
Global Polymerase Chain Reaction (PCR) Market Size by Indication & CAGR (2026-2033)
- Market Overview
- Infectious Diseases
- Oncology
- Genetic Disorders
- Others
Global Polymerase Chain Reaction (PCR) Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Industries
- Diagnostic Centers
- Academic & Research Organizations
Global Polymerase Chain Reaction (PCR) Market Size & CAGR (2026-2033)
- North America (Type, Product, Indication, End User)
- US
- Canada
- Europe (Type, Product, Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Type, Product, Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Type, Product, Indication, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Type, Product, Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- bioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QIAGEN (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QuantuMDx Group Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eppendorf (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fluidigm Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Microsynth AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- JN Medsys (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio Inc (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
全球聚合酵素链锁反应（PCR）市场－2025-2030年预测
2025年全球生物聚合酵素链锁反应（PCR）技术市场报告
聚合酵素链锁反应市场按产品类型、技术、应用和最终用户划分－2025-2032年全球预测2025年定量聚合酵素链锁反应（qPCR）仪器全球市场报告2025年聚合酵素链锁反应（PCR）全球市场报告
2025 年至 2033 年聚合酶炼式反应市场报告（按产品、最终用户和地区）2025年聚合酵素链锁反应（PCR）分子诊断全球市场报告2026 年至 2032 年聚合酵素链锁反应(PCR) 市场（按产品、应用、最终用户和地区）全球聚合酵素链锁反应（PCR）耗材市场：市场规模（按产品类型、技术、应用、最终用户和地区划分）、未来预测全球聚合酶炼式反应市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测